Literature DB >> 32334051

Cullin-RING Ligase 5: Functional characterization and its role in human cancers.

Yongchao Zhao1, Xiufang Xiong2, Yi Sun3.   

Abstract

Cullin-RING ligase 5 (CRL5) is a multi-protein complex and consists of a scaffold protien cullin 5, a RING protein RBX2 (also known as ROC2 or SAG), adaptor proteins Elongin B/C, and a substrate receptor protein SOCS. Through targeting a variety of substrates for proteasomal degradation or modulating various protein-protein interactions, CRL5 is involved in regulation of many biological processes, such as cytokine signal transduction, inflammation, viral infection, and oncogenesis. As many substrates of CRL5 are well-known oncoproteins or tumor suppressors, abnormal regulation of CRL5 is commonly found in human cancers. In this review, we first briefly introduce each of CRL5 components, and then discuss the biological processes regulated by four members of SOCS-box-containing substrate receptor family through substrate degradation. We next describe how CRL5 is hijacked by a variety of viral proteins to degrade host anti-viral proteins, which facilitates virus infection. We further discuss the regulation of CUL5 and its various roles in human cancers, acting as either a tumor suppressor or an oncoprotein in a context-dependent manner. Finally, we propose novel insights for future perspectives on the validation of cullin5 and other CRL5 components as potential targets, and possible targeting strategies to discover CRL5 inhibitors for anti-cancer and anti-virus therapies.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  CRL5; Cullin 5; RBX2/SAG; SOCS; Tumorigenesis

Year:  2020        PMID: 32334051     DOI: 10.1016/j.semcancer.2020.04.003

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  9 in total

1.  Targeting Protein Neddylation to Inactivate Cullin-RING Ligases by Gossypol: A Lucky Hit or a New Start?

Authors:  Qing Yu; Yi Sun
Journal:  Drug Des Devel Ther       Date:  2021-01-06       Impact factor: 4.162

2.  SOCS6 promotes radiosensitivity and decreases cancer cell stemness in esophageal squamous cell carcinoma by regulating c-Kit ubiquitylation.

Authors:  Xuanzi Sun; Yuchen Sun; Jing Li; Xu Zhao; Xiaobo Shi; Tuotuo Gong; Shupei Pan; Zhongqiang Zheng; Xiaozhi Zhang
Journal:  Cancer Cell Int       Date:  2021-03-12       Impact factor: 5.722

Review 3.  A Comprehensive Review of Biological Roles and Interactions of Cullin-5 Protein.

Authors:  Iqra Bano; Anum Sumera Soomro; Syed Qamar Abbas; Amirhossein Ahmadi; Syed Shams Ul Hassan; Tapan Behl; Simona Bungau
Journal:  ACS Omega       Date:  2022-02-11

4.  Rab40c regulates focal adhesions and PP6 activity by controlling ANKRD28 ubiquitylation.

Authors:  Ke-Jun Han; Valeryia Mikalayeva; Scott A Gerber; Arminja N Kettenbach; Vytenis A Skeberdis; Rytis Prekeris
Journal:  Life Sci Alliance       Date:  2022-05-05

Review 5.  Ubiquitin Proteasome Pathway Transcriptome in Epithelial Ovarian Cancer.

Authors:  Jerry Vriend; Mark W Nachtigal
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

6.  The proteolytic landscape of cells exposed to non-lethal stresses is shaped by executioner caspases.

Authors:  María Del Carmen Conde-Rubio; Roman Mylonas; Christian Widmann
Journal:  Cell Death Discov       Date:  2021-06-19

Review 7.  Targeting NEDDylation as a Novel Approach to Improve the Treatment of Head and Neck Cancer.

Authors:  Trace M Jones; Jennifer S Carew; Julie E Bauman; Steffan T Nawrocki
Journal:  Cancers (Basel)       Date:  2021-06-29       Impact factor: 6.575

Review 8.  Emerging Molecular Dependencies of Mutant EGFR-Driven Non-Small Cell Lung Cancer.

Authors:  Dylan A Farnsworth; Yankuan T Chen; Georgia de Rappard Yuswack; William W Lockwood
Journal:  Cells       Date:  2021-12-16       Impact factor: 6.600

Review 9.  Roles of Cullin-RING Ubiquitin Ligases in Cardiovascular Diseases.

Authors:  Stephanie Diaz; Kankan Wang; Benita Sjögren; Xing Liu
Journal:  Biomolecules       Date:  2022-03-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.